ES2634613T3 - Métodos de obtención de leche estéril y composiciones de la misma - Google Patents
Métodos de obtención de leche estéril y composiciones de la misma Download PDFInfo
- Publication number
- ES2634613T3 ES2634613T3 ES07811645.6T ES07811645T ES2634613T3 ES 2634613 T3 ES2634613 T3 ES 2634613T3 ES 07811645 T ES07811645 T ES 07811645T ES 2634613 T3 ES2634613 T3 ES 2634613T3
- Authority
- ES
- Spain
- Prior art keywords
- protein
- fraction
- milk
- whole milk
- skimmed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- A23C9/206—Colostrum; Human milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C3/00—Preservation of milk or milk preparations
- A23C3/02—Preservation of milk or milk preparations by heating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
- A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
- A23C9/1422—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of milk, e.g. for separating protein and lactose; Treatment of the UF permeate
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C2210/00—Physical treatment of dairy products
- A23C2210/25—Separating and blending
- A23C2210/252—Separating a milk product in at least two fractions followed by treatment of at least one of the fractions and remixing at least part of the two fractions
Landscapes
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Water Supply & Treatment (AREA)
- Dairy Products (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Un método para la obtención de una composición de leche humana que comprende: (a) filtración de leche entera agrupada a través de un filtro de 100-400 micrómetros; (b) tratamiento térmico de la leche entera a 58-65 °C durante 20-40 minutes; (c) separación de la leche entera en una porción desnatada y una porción de grasa; (d) ultrafiltración de la porción desnatada a través de uno o más ultrafiltros para obtener una porción permeada y una fracción retenida desnatada rica en proteínas; (e) mezclado de una fracción de la porción de grasa con la fracción retenida desnatada rica en proteínas para obtener una composición de leche humana.
Description
12
Claims (11)
- REIVINDICACIONES1. Un método para la obtención de una composición de leche humanaque comprende: 5
- (a)
- filtración de leche entera agrupada a través de un filtro de 100-400 micrómetros;
- (b)
- tratamiento térmico de la leche entera a 58-65 °C durante 20-40 minutes;
- (c)
- separación de la leche entera en una porción desnatada y una porción de grasa;
(d) ultrafiltración de la porción desnatada a través de uno o más ultrafiltros para obtener una porción permeada y 10 una fracción retenida desnatada rica en proteínas;(e) mezclado de una fracción de la porción de grasa con la fracción retenida desnatada rica en proteínas para obtener una composición de leche humana. - 2. El método de la reivindicación 1, que comprende además el análisis de una muestra de la leche entera para 15 determinar la presencia de VIH1, VIH2, VHB, VHC, HTLVI, HTLVII, sífilis y B. cereus antes de la filtración.
- 3. El método de la reivindicación 1, en el que el filtrado de la leche entera en la etapa (a) se realiza a través de un tamiz de filtro de 200 micrómetros.20 4. El método de la reivindicación 1, en el que el tratamiento térmico de la leche entera en la etapa (b) se realiza a 63 °C durante 30 minutos.
- 5. El método de la reivindicación 1 en el que la porción de grasa obtenida en la etapa (c) se sigue procesando paraobtener una porción de leche desnatada adicional. 25
- 6. El método de la reivindicación 5, en el que la porción desnatada adicional se agrupa con la porción desnatada obtenida en la etapa (c).
- 7. El método de la reivindicación 1, que comprende además recoger y filtrar la fracción permeada obtenida en la 30 etapa (d) para obtener una segunda fracción retenida.
- 8. El método de la reivindicación 7 en el que la segunda fracción retenida se añade a la primera fracción retenida obtenida en la etapa (d) de la reivindicación 1.35 9. El método de la reivindicación 1 en el que la ultrafiltración utiliza una membrana de ultrafiltración que impide el paso de cualquier sustancia con un peso molecular superior a 1-40 kDa.
- 10. El método de las reivindicaciones 1 o 7 que comprende además el lavado de los ultrafiltros con la fracciónpermeada obtenida en la etapa (d) de la reivindicación 1 para obtener un lavado de proteína y la adición del lavado 40 de proteína a la fracción retenida desnatada rica en proteína obtenida en la etapa (d).
- 11. El método de la reivindicación 1 en el que tras la pasteurización, se analiza la leche pasteurizada para determinar el contenido nutricional, el contenido de proteínas, los factores específicos y se ajusta a un nivel deseado.45
- 12. El método de la reivindicación 1, en el que se pasteuriza la composición de leche humana obtenida en la etapa (e).
- 13. Una composición de leche humana obtenida según el método de una cualquiera de las reivindicaciones 50 anteriores que comprende:
- (a)
- un constituyente de proteína de 20-70 mg/ml;
- (b)
- un constituyente de grasa de 35-85 mg/ml,
(c) un constituyente de hidratos de carbono de 70-115 mg/ml. 5516
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84137106P | 2006-08-30 | 2006-08-30 | |
US841371P | 2006-08-30 | ||
US86774806P | 2006-11-29 | 2006-11-29 | |
US867748P | 2006-11-29 | ||
PCT/US2007/019234 WO2008027572A1 (en) | 2006-08-30 | 2007-08-30 | Methods of obtaining sterile milk and compositions thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2634613T3 true ES2634613T3 (es) | 2017-09-28 |
Family
ID=39136247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES07811645.6T Active ES2634613T3 (es) | 2006-08-30 | 2007-08-30 | Métodos de obtención de leche estéril y composiciones de la misma |
Country Status (6)
Country | Link |
---|---|
US (7) | US9149052B2 (es) |
EP (1) | EP2063722B1 (es) |
JP (2) | JP5448819B2 (es) |
ES (1) | ES2634613T3 (es) |
PT (1) | PT2099321T (es) |
WO (1) | WO2008027572A1 (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020182243A1 (en) | 2001-05-14 | 2002-12-05 | Medo Elena Maria | Method of producing nutritional products from human milk tissue and compositions thereof |
WO2007035870A2 (en) | 2005-09-20 | 2007-03-29 | Prolacta Bioscience, Inc. | A method for testing milk |
CA2706722C (en) | 2006-11-29 | 2016-01-12 | Prolacta Bioscience, Inc. | Human milk compositions and methods of making and using same |
JP5616066B2 (ja) | 2006-12-08 | 2014-10-29 | プロラクタ バイオサイエンス,インコーポレイテッド | ヒト脂質組成物ならびにその製造および使用方法 |
US8927027B2 (en) | 2008-12-02 | 2015-01-06 | Prolacta Bioscience | Human milk permeate compositions and methods of making and using same |
CN103987265B (zh) | 2011-08-03 | 2017-05-24 | 普罗莱克塔生物科学公司 | 减少细菌污染的人乳微滤 |
MX354727B (es) * | 2011-10-18 | 2018-03-16 | Nestec Sa | Composicion para uso en la promocion de absorcion de magnesio y/o retencion de magnesio. |
US9458230B2 (en) * | 2013-01-04 | 2016-10-04 | Wisconsin Alumni Research Foundation | Secretory IGA compositions, methods of making and methods of use thereof |
US20140271980A1 (en) * | 2013-03-13 | 2014-09-18 | Prolacta Bioscience | Adulteration testing of human milk |
ES2843254T3 (es) | 2013-03-13 | 2021-07-16 | Prolacta Bioscience Inc | Productos de leche humana rica en grasas |
ITMI20131690A1 (it) * | 2013-10-14 | 2015-04-15 | Consiglio Nazionale Ricerche | Composizione alimentare. |
US20170367364A1 (en) * | 2014-12-30 | 2017-12-28 | Prolacta Bioscience. Inc. | Methods of preventing and treating bronchopulmonary dysplasia using high fat human milk products |
EP3397064A4 (en) | 2015-12-30 | 2019-10-30 | Prolacta Bioscience, Inc. | HUMAN MILK PRODUCTS USEFUL IN PRE- AND POST-OPERATIVE CARE |
SG11201902969VA (en) * | 2016-10-04 | 2019-05-30 | Imb Inc | Methods and systems for generating a sterilized human milk product |
WO2020123121A1 (en) * | 2018-12-11 | 2020-06-18 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods of screening antibodies for treating and/or preventing necrotizing enterocolitis (nec) |
US12070044B2 (en) | 2019-02-22 | 2024-08-27 | Aquero Canada Ltd. | Fortified milk compositions and their processes of preparation |
BR112022005578A2 (pt) | 2019-09-24 | 2022-09-20 | Prolacta Bioscience Inc | Composições e métodos para tratamento de doenças inflamatórias e imunes |
WO2021146561A1 (en) | 2020-01-17 | 2021-07-22 | Prolacta Bioscience, Inc. | Feeding protocol for optimal growth of preterm infants |
CN116322371A (zh) | 2020-08-14 | 2023-06-23 | 普罗莱克塔生物科学公司 | 与细菌疗法一起使用的人乳寡糖组合物 |
KR20230131228A (ko) | 2021-01-12 | 2023-09-12 | 프롤랙타 바이오사이언스, 인코포레이티드 | 신바이오틱 치료 요법 |
CA3205754A1 (en) | 2021-01-22 | 2022-07-28 | Biranchi Patra | Topical human milk formulations |
WO2024130119A2 (en) | 2022-12-16 | 2024-06-20 | Prolacta Bioscience, Inc. | Synbiotic compositions for short chain fatty acid production |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2148100A (en) * | 1936-07-01 | 1939-02-21 | M & R Dietetic Lab Inc | Treatment of milk fluids |
JPS5948964B2 (ja) * | 1978-01-11 | 1984-11-30 | 雪印乳業株式会社 | 人乳に類似した育児用乳の製造法 |
JPS6133895Y2 (es) * | 1980-02-29 | 1986-10-03 | ||
US4462932A (en) * | 1983-06-22 | 1984-07-31 | Purdue Research Foundation | Isolation of native casein by cryodestabilization |
JPS6467141A (en) * | 1987-09-08 | 1989-03-13 | Kougakushiya Kk | Method for removing various germs and somatic cell from cow's milk and apparatus therefor |
JP3061649B2 (ja) * | 1991-02-08 | 2000-07-10 | 森永乳業株式会社 | 抗アレルギー性調製乳 |
WO1993020717A2 (en) * | 1992-04-13 | 1993-10-28 | Research Corporation Technologies, Inc. | Reducing gastrointestinal irritation in infant nutrition |
JP3150504B2 (ja) * | 1993-02-26 | 2001-03-26 | 雪印乳業株式会社 | 低乳糖乳製品およびその製造方法 |
DE4424935C1 (de) * | 1994-07-14 | 1996-03-21 | Immuno Ag | Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung |
US5670196A (en) * | 1995-04-12 | 1997-09-23 | Galagen Inc. | Method for microfiltration of milk or colostral whey |
JPH09275897A (ja) * | 1996-04-16 | 1997-10-28 | Takamichi Tominaga | ミルクの調整法及び粉ミルク計量器及び粉ミルク計量器の組合せ |
US6194009B1 (en) * | 1996-11-22 | 2001-02-27 | Princeton Nutrition, Llc | Refrigeration-shelf-stable ultra-pasteurized or pasteurized infant formula |
US6652900B2 (en) | 1997-03-14 | 2003-11-25 | Tetra Laval Holdings & Finance S.A. | Method and plant for producing a sterile milk product |
NL1010829C2 (nl) * | 1998-12-16 | 2000-06-19 | Prolion Bv | Inrichting en werkwijze voor het melken van dieren en een vervuilingsmeter. |
US6294206B1 (en) * | 1999-04-09 | 2001-09-25 | Abbott Laboratories | Powdered human milk fortifier |
WO2001036442A1 (en) * | 1999-11-17 | 2001-05-25 | Jiuping Ji | Simultaneous detection of hbv, hcv and hiv in plasma samples using a multiplex capture assay |
US6932967B2 (en) * | 2001-03-22 | 2005-08-23 | Michael R. Simon | Human medical treatment by aerosol inhalation of immunoglobulin A |
WO2002090572A2 (en) * | 2001-05-09 | 2002-11-14 | Third Wave Technologies, Inc. | Nucleic acid detection in pooled samples |
US20020182243A1 (en) * | 2001-05-14 | 2002-12-05 | Medo Elena Maria | Method of producing nutritional products from human milk tissue and compositions thereof |
US20070196506A2 (en) * | 2002-02-04 | 2007-08-23 | Bristol-Myers Squibb Company | Improved tolerance nutritional product to supplement human milk |
FI115752B (fi) * | 2002-05-14 | 2005-07-15 | Valio Oy | Menetelmä käytettäväksi vähälaktoosisen tai laktoosittoman maitotuotteen valmistamiseksi |
NZ527434A (en) * | 2003-08-07 | 2006-03-31 | Fonterra Co Operative Group | Production of protein composition from a dairy stream and its use as an ingredient in the manufacture of a cheese |
EP1787114A1 (en) * | 2004-09-10 | 2007-05-23 | Medela Holding AG | Method for analysing and treating human milk and system therefore |
EP1637043A1 (en) * | 2004-09-17 | 2006-03-22 | Medela Holding AG | Human milk fortifiers and methods for their production |
US20080187619A1 (en) * | 2004-09-10 | 2008-08-07 | Medela Holding Ag | Human Milk Fortifiers and Methods for Their Production |
-
2007
- 2007-08-30 JP JP2009526751A patent/JP5448819B2/ja active Active
- 2007-08-30 US US12/438,789 patent/US9149052B2/en active Active
- 2007-08-30 EP EP07811645.6A patent/EP2063722B1/en active Active
- 2007-08-30 WO PCT/US2007/019234 patent/WO2008027572A1/en active Application Filing
- 2007-08-30 ES ES07811645.6T patent/ES2634613T3/es active Active
- 2007-11-29 PT PT78649217T patent/PT2099321T/pt unknown
-
2012
- 2012-07-23 JP JP2012162801A patent/JP5770690B2/ja active Active
-
2015
- 2015-08-21 US US14/832,920 patent/US20160050949A1/en not_active Abandoned
-
2017
- 2017-06-21 US US15/629,278 patent/US20170347675A1/en not_active Abandoned
-
2018
- 2018-10-24 US US16/169,204 patent/US20190053508A1/en not_active Abandoned
- 2018-11-14 US US16/191,129 patent/US20190075809A1/en not_active Abandoned
-
2019
- 2019-07-08 US US16/504,994 patent/US20190327994A1/en not_active Abandoned
-
2022
- 2022-04-12 US US17/719,098 patent/US20220232844A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2008027572A1 (en) | 2008-03-06 |
US20160050949A1 (en) | 2016-02-25 |
US20190053508A1 (en) | 2019-02-21 |
EP2063722B1 (en) | 2017-05-03 |
US20170347675A1 (en) | 2017-12-07 |
JP2012231793A (ja) | 2012-11-29 |
PT2099321T (pt) | 2017-07-21 |
US20190327994A1 (en) | 2019-10-31 |
US9149052B2 (en) | 2015-10-06 |
JP2010502186A (ja) | 2010-01-28 |
JP5770690B2 (ja) | 2015-08-26 |
JP5448819B2 (ja) | 2014-03-19 |
EP2063722A4 (en) | 2011-05-18 |
EP2063722A1 (en) | 2009-06-03 |
US20190075809A1 (en) | 2019-03-14 |
US20220232844A1 (en) | 2022-07-28 |
US20110256269A1 (en) | 2011-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2634613T3 (es) | Métodos de obtención de leche estéril y composiciones de la misma | |
Giangrande | Six characters in search of an author: the history of the nomenclature of coagulation factors. | |
Kodavanti et al. | The spontaneously hypertensive rat as a model of human cardiovascular disease: evidence of exacerbated cardiopulmonary injury and oxidative stress from inhaled emission particulate matter | |
Burt et al. | Does low birthweight increase the risk of caries? A systematic review | |
Florén et al. | ColoPlus, a new product based on bovine colostrum, alleviates HIV-associated diarrhoea | |
Cameron et al. | The clinical association of macrocytic anemia with intestinal stricture and anastomosis | |
Parsons | Celiac Disease: Rachford Memorial Lectures | |
ES2234552T3 (es) | Un metodo para tratamiento de calostro. | |
Vanholder et al. | Endotoxin transfer through dialysis membranes: small-versus large-pore membranes | |
UA52601C2 (uk) | Спосіб виробництва питного молока з тривалим терміном зберігання | |
RU2016114740A (ru) | Способ гуманизирования обезжиренного молока животных | |
Prasongwatana et al. | Chemical components of urinary stones according to age and sex of adult patients | |
Todd et al. | On the haemolytic immune isolysins of the ox and their relation to the question of individuality and blood-relationship | |
Emektar et al. | Determination of factors associated with perforation in patients with geriatric acute appendicitis | |
Datta et al. | Microalbuminuria as a predictor of early glomerular injury in children with sickle cell disease | |
World Health Organization | Global measles and rubella laboratory network—update | |
Al Hadidi et al. | Loeffler's syndrome secondary to hyperinfection by Strongyloides stercoralis associated with methotrexate in a patient with rheumatoid arthritis | |
Garrido-Castañé et al. | Cardiopulmonary helminths in foxes from the Pyrenees | |
Wesołowska et al. | Concurrent infection of a young tourist by hookworm and during low budget travel in Southeast Asia | |
El-Mandrawy et al. | Molecular Characterization, Hematological and Biochemical Studies on Foot and Mouth Disease Virus Serotype O in Buffaloes and Cows in Dakahlia Governorate, Egypt | |
Yıldız et al. | Epidemiological, laboratory and clinical features of childhood hydatid disease | |
Porter | Remarks on intestinal parasites in Montreal, and the relation of Entamoeba histolytica to colitis | |
Jorfizadeh et al. | Relationships of Students’ Mental Well-being with Mothers’ Emotional Breakdown and Marital Justice Mediated by Mothers’ Marital Intimacy | |
Olaru et al. | „GASTRITIS” MASKING LATE SYMPTOMS OF MUSHROOM POISONING IN A TEENAGER. | |
JP2017525349A (ja) | 個人別濃縮人乳組成物の製造のための装置及びキット、並びにその製造及び使用方法 |